Literature DB >> 17092650

Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum.

Ken-ichi Tanaka1, Norio Ogawa, Masato Asanuma.   

Abstract

To clarify the possible role of in the in vivo toxic effects of 6-hydroxydopamine (6-OHDA), especially caspase activations, we examined its effects on striatal lipid peroxidation (LPO) and caspase activations in 6-OHDA-lesioned mice. Both dopamine (DA) levels and DA turnover were significantly changed by the 6-OHDA i.c.v. injection compared with the pre-injection level in the striatum. In addition, the striatal glutathione (GSH) content fluctuated and was significantly decreased both at 3 and 14 days after 6-OHDA i.c.v. injection. Moreover, superoxide dismutase (SOD) activity at 7 days after 6-OHDA i.c.v. injection was transiently and significantly increased compared with the pre-injection level. The levels of thiobarbituric acid-reactive substances (TBA-RS) were significantly increased at 1, 3 and 14 days. 6-OHDA significantly increased the activities of all three caspases, except for the caspase-3 activity at 7 days throughout the experimental period compared with the pre-injection level. In conclusion, 6-OHDA-induced dopaminergic dysfunction is mainly due to caspase activations by increases in oxidative stress in the mouse striatum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092650     DOI: 10.1016/j.neulet.2006.08.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  ER stress inhibits neuronal death by promoting autophagy.

Authors:  Antoine Fouillet; Clemence Levet; Angelique Virgone; Marion Robin; Pierre Dourlen; Jennifer Rieusset; Elise Belaidi; Michel Ovize; Monique Touret; Serge Nataf; Bertrand Mollereau
Journal:  Autophagy       Date:  2012-06-01       Impact factor: 16.016

2.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

3.  Getting the better of ER stress.

Authors:  Bertrand Mollereau; Serge Manié; Francesco Napoletano
Journal:  J Cell Commun Signal       Date:  2014-10-30       Impact factor: 5.782

4.  KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity.

Authors:  Luis Arturo Fonseca-Fonseca; Yanier Nuñez-Figueredo; Jeney Ramírez Sánchez; Maylin Wong Guerra; Estael Ochoa-Rodríguez; Yamila Verdecia-Reyes; René Delgado Hernádez; Noelio J Menezes-Filho; Teresa Cristina Silva Costa; Wagno Alcântara de Santana; Joana L Oliveira; Juan Segura-Aguilar; Victor Diogenes Amaral da Silva; Silva Lima Costa
Journal:  Neurotox Res       Date:  2018-01-02       Impact factor: 3.911

5.  Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.

Authors:  Renata Pietsch Ribeiro; Eduardo Luiz Gasnhar Moreira; Danúbia Bonfanti Santos; Dirleise Colle; Alessandra Antunes Dos Santos; Kaite Cristiane Peres; Claudia Pinto Figueiredo; Marcelo Farina
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

6.  Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson's disease.

Authors:  Mojtaba Dolatshahi; Yaghoob Farbood; Alireza Sarkaki; Seyed Mohammad Taqhi Mansouri; Ali Khodadadi
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

7.  Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.

Authors:  Gabriela P Chaves-Kirsten; Caio H Y Mazucanti; Caroline C Real; Bruna M Souza; Luiz R G Britto; Andréa S Torrão
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

Review 8.  Oxidative Stress Evaluation in Ischemia Reperfusion Models: Characteristics, Limits and Perspectives.

Authors:  Pauline Chazelas; Clara Steichen; Frédéric Favreau; Patrick Trouillas; Patrick Hannaert; Raphaël Thuillier; Sébastien Giraud; Thierry Hauet; Jérôme Guillard
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.